1.
PL Zinzani, L Alinari, M Tani, M Fina, S Pileri, M Baccarani. Preliminary observations of a phase II study of reduced-dose alemtuzumab treatment in patients with pretreated T-cell lymphoma. haematol [Internet]. 2005Jan.1 [cited 2022Dec.6];90(5):702-3. Available from: https://haematologica.org/article/view/3537